Abstract:The bystander effect (BSE) is an interesting and important communication. We confirmed that mixtures of tumor cells property of the herpes thymidine kinase/ganciclovir resistant to the BSE did not show dye transfer from cell to (hTK/GCV) system of gene therapy for cancer. With the cell while bystander-sensitive tumor cells did. Dieldrin, a BSE, not only are the hTK expressing cells killed upon gandrug known to decrease GJ communication, diminished ciclovir (GCV) exposure but also neighboring wild-type dye tran… Show more
“…27 Gap junctions, cellular channels built up by proteins called connexins, are of special interest because they allow the transfer of toxic GCV metabolites from HSVtk-transfected tumor cells to the wild-type tumor cells, thus contributing to cell death. 27,28 Most tumors and cancer cell lines have lost their ability to communicate through gap junctions.…”
Section: Connexin-43 Was Expressed In Monolayers and Spheroids Of Thementioning
confidence: 99%
“…27 Gap junctions, cellular channels built up by proteins called connexins, are of special interest because they allow the transfer of toxic GCV metabolites from HSVtk-transfected tumor cells to the wild-type tumor cells, thus contributing to cell death. 27,28 Most tumors and cancer cell lines have lost their ability to communicate through gap junctions. 29,30 Since in MCS, the expression of connexins is usually downregulated with respect to monolayers, 31 we investigated the expression of connexin-43 (Cx43), a major gap junction-forming connexin protein in these 2D-and 3D-cultured tumor cells.…”
Section: Connexin-43 Was Expressed In Monolayers and Spheroids Of Thementioning
We have developed multicellular spheroids (MCS) established from LM05e and LM3 spontaneous Balb/c-murine mammary adenocarcinoma and B16 C57-murine melanoma derived cell lines as an in vitro model to study the efficacy of the herpes simplex virus thymidine kinase/ganciclovir (HSVtk/GCV) suicide system. We demonstrated for the first time that HSVtk-expressing cells assembled as MCS manifested a GCV resistance phenotype compared to the same cells grown as sparse monolayers. HSVtkexpressing LM05e, LM3 and B16 spheroids were 16-, three-and nine-fold less sensitive to GCV than their respective monolayers, even though they could express transgenes 10-, eight-and five-fold more efficiently. Mixed populations of HSVtkĂ and their respective bgal-expressing cells displayed a cell-type specific bystander effect that was higher in monolayers than in MCS. However, HSVtkĂexpressing cells in two-or three-dimensional cultures were always significantly more sensitive to GCV than the bgal-expressing counterparts, supporting the feasibility of this suicide approach in vivo. We present evidence showing that HSVtkexpressing tumor cells, when transferred from monolayers to MCS, displayed: (i) lower GCV cytotoxic activity and bystander effect; (ii) higher and efficient expression of genes transferred as lipoplexes; (iii) lower cell proliferation rates; and (iv) changes in intracellular Bax/Bcl-xL rheostat of mitochondria-mediated apoptosis. Cancer Gene Therapy ( A ntitumor suicide gene therapy is one of the emerging strategies against cancer. 1 It consists of the introduction into cancer cells of a gene, whose product is capable of converting a nontoxic prodrug into a cytotoxic drug. 2 One of such suicide genes, the thymidine kinase gene from the herpes simplex virus (HSVtk), in combination with the prodrug ganciclovir (GCV), has been extensively and successfully used for the treatment of a variety of cancers in some animal models. HSVtk can efficiently phosphorylate the guanosine analogue GCV and allows its further transformation, after subsequent phosphorylation by cellular kinases, into cytotoxic ganciclovir-triphosphate, which inhibits cellular DNA polymerases. 3 GCV-induced apoptosis is due to incorporation of the drug into DNA resulting in replication-dependent formation of DNA double-strand breaks and, at later stages, S and G 2 /M arrest. 4 As this therapeutic gene cannot be easily introduced into the whole cell population of a tumor, the successful eradication of tumors depends on a phenomenon called the bystander effect, by which the unmodified adjacent tumor cells are also sensitive to the GCV cytotoxic effect. 5,6 This bystander effect permits that the transfection of only a minority of tumor cells may lead to effective tumor regression. 6 Despite extensive preclinical evaluation both in vitro and in vivo in several experimental models, no studies have been undertaken examining a nonviral HSVtk/GCV suicide system in spheroids, a model that mimics the microregions of solid tumors. 7 Multicellular spheroids (MCS) have been us...
“…27 Gap junctions, cellular channels built up by proteins called connexins, are of special interest because they allow the transfer of toxic GCV metabolites from HSVtk-transfected tumor cells to the wild-type tumor cells, thus contributing to cell death. 27,28 Most tumors and cancer cell lines have lost their ability to communicate through gap junctions.…”
Section: Connexin-43 Was Expressed In Monolayers and Spheroids Of Thementioning
confidence: 99%
“…27 Gap junctions, cellular channels built up by proteins called connexins, are of special interest because they allow the transfer of toxic GCV metabolites from HSVtk-transfected tumor cells to the wild-type tumor cells, thus contributing to cell death. 27,28 Most tumors and cancer cell lines have lost their ability to communicate through gap junctions. 29,30 Since in MCS, the expression of connexins is usually downregulated with respect to monolayers, 31 we investigated the expression of connexin-43 (Cx43), a major gap junction-forming connexin protein in these 2D-and 3D-cultured tumor cells.…”
Section: Connexin-43 Was Expressed In Monolayers and Spheroids Of Thementioning
We have developed multicellular spheroids (MCS) established from LM05e and LM3 spontaneous Balb/c-murine mammary adenocarcinoma and B16 C57-murine melanoma derived cell lines as an in vitro model to study the efficacy of the herpes simplex virus thymidine kinase/ganciclovir (HSVtk/GCV) suicide system. We demonstrated for the first time that HSVtk-expressing cells assembled as MCS manifested a GCV resistance phenotype compared to the same cells grown as sparse monolayers. HSVtkexpressing LM05e, LM3 and B16 spheroids were 16-, three-and nine-fold less sensitive to GCV than their respective monolayers, even though they could express transgenes 10-, eight-and five-fold more efficiently. Mixed populations of HSVtkĂ and their respective bgal-expressing cells displayed a cell-type specific bystander effect that was higher in monolayers than in MCS. However, HSVtkĂexpressing cells in two-or three-dimensional cultures were always significantly more sensitive to GCV than the bgal-expressing counterparts, supporting the feasibility of this suicide approach in vivo. We present evidence showing that HSVtkexpressing tumor cells, when transferred from monolayers to MCS, displayed: (i) lower GCV cytotoxic activity and bystander effect; (ii) higher and efficient expression of genes transferred as lipoplexes; (iii) lower cell proliferation rates; and (iv) changes in intracellular Bax/Bcl-xL rheostat of mitochondria-mediated apoptosis. Cancer Gene Therapy ( A ntitumor suicide gene therapy is one of the emerging strategies against cancer. 1 It consists of the introduction into cancer cells of a gene, whose product is capable of converting a nontoxic prodrug into a cytotoxic drug. 2 One of such suicide genes, the thymidine kinase gene from the herpes simplex virus (HSVtk), in combination with the prodrug ganciclovir (GCV), has been extensively and successfully used for the treatment of a variety of cancers in some animal models. HSVtk can efficiently phosphorylate the guanosine analogue GCV and allows its further transformation, after subsequent phosphorylation by cellular kinases, into cytotoxic ganciclovir-triphosphate, which inhibits cellular DNA polymerases. 3 GCV-induced apoptosis is due to incorporation of the drug into DNA resulting in replication-dependent formation of DNA double-strand breaks and, at later stages, S and G 2 /M arrest. 4 As this therapeutic gene cannot be easily introduced into the whole cell population of a tumor, the successful eradication of tumors depends on a phenomenon called the bystander effect, by which the unmodified adjacent tumor cells are also sensitive to the GCV cytotoxic effect. 5,6 This bystander effect permits that the transfection of only a minority of tumor cells may lead to effective tumor regression. 6 Despite extensive preclinical evaluation both in vitro and in vivo in several experimental models, no studies have been undertaken examining a nonviral HSVtk/GCV suicide system in spheroids, a model that mimics the microregions of solid tumors. 7 Multicellular spheroids (MCS) have been us...
“…22 In HSV-TK/ GCV therapy, bystander cytotoxicity has been effective at killing cocultures of HSV-TK-expressing and HSV-TKnon-expressing cells in vitro and at reducing tumor size in vivo. 10,11,[29][30][31][32][33][34][35][36] HSV-TK expression in as few as 10% of tumor cells in vivo resulted in tumor regression or a significant reduction in tumor growth when GCV was administered. Bystander cytotoxicity has been attributed to the transfer of phosphorylated GCV metabolites from HSV-TK-expressing cells to non-HSV-TK-expressing bystander cells, presumably via protein channels known as gap junctions.…”
The role of gap junctional intercellular communication (GJIC) in bystander killing with herpes simplex virus thymidine kinase (HSV-TK) and ganciclovir (GCV) was evaluated in U251 cells expressing a dominant-negative connexin 43 cDNA (DN14), and in HeLa cells, reportedly devoid of connexin protein. These cell lines both exhibited 0% GJIC when assayed by Lucifer Yellow fluorescent dye microinjection. Bystander cytotoxicity was still apparent in 50:50 cocultures of DN14 and HSV-TK-expressing U251 cells, but not in 50:50 cocultures of HeLa cells. However, the sensitivity of HeLa HSV-TK-expressing cells to GCV decreased nearly 100-fold (IC 90 Œ 109 mM) when cocultured with bystander cells compared to results in 100% cultures of HSV-TK-expressing cells (IC 90 Œ 1.2 mM). A more sensitive flow cytometry technique to measure GJIC over 24 h revealed that the DN14 and HeLa cells exhibited detectable levels of communication (29 and 23%, respectively). Transfer of phosphorylated GCV to HeLa bystander cells occurred within 4 h after drug addition, and GCV triphosphate (GCVTP) accumulated to 213784 pmol/10 6 cells after 24 h. In addition, GCVTP levels were decreased in HSV-TK-expressing cells in coculture (867733 pmol/10 6 cells) compared to 100% cultures of HSV-TK-expressing cells (17737188 pmol/10 6 cells). The half-life of GCVTP in the HSV-TK-expressing cells was approximately four times that measured in the bystander cells (12.3 and 3.1 h, respectively). These data suggest that the lack of bystander cytotoxicity in HeLa cocultures is due to low transfer of phosphorylated GCV and a rapid half-life of GCVTP in the bystander cells. Thus, GCV phosphate transfer to non-HSV-TK-expressing bystander cells may mediate either bystander cell killing or sparing of HSV-TK-positive cells, depending upon the cell specific drug metabolism.
“…Interestingly, the effects of this type of vectors are amplified by the bystander effect, caused by the passage of the toxic metabolites to cells connected by gap junctions. [23][24][25] This effect increases the therapeutic capacity of this approach; however, a limitation to this system is that the level of intercellular communication varies in different tumors, and may even be blocked in the later stages of carcinogenesis. 24,26,27 We consider, as we will discuss in more detail presently, that the procedure we put forward in this paper shows improvements with respect to the transfer of HSV-tk, because it affects neighboring cells that need not to be joined by gap junctions, thus increasing its range of therapeutic activity.…”
Gliomas are the most frequent primary tumors of the central nervous system, and their clinical prognosis remains very poor. Because of the characteristics of gliomas, gene therapy appears as a potentially relevant strategy for their treatment. However, the inability of viral vectors to transfer the therapeutic genes to a significantly high number of tumor cells, due to their limited diffusion and distribution, remains a critical obstacle for their application treating gliomas. We have demonstrated that the overexpression of growth arrest specific1 (Gas1) induces cell arrest and apoptosis and eliminates glioma cells in vitro and when implanted in mice. To improve the therapeutic range of Gas1, we generated lentiviral vectors coding for a soluble form of Gas1. Here, we show that cells infected with this virus produce the mutant protein, that acting both in autocrine and paracrine manners, causes death of infected and neighbor cells, thus importantly enhancing the effect of Gas1. Furthermore, the administration of this vector, or cells expressing it, inhibit the growth of tumors inoculated in mice. We present a gene therapy strategy that increases the effect of the therapeutic molecule by eliminating not just the infected cells that express Gas1, but neighbor non-infected cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.